Hi, I’m Celine.
I am the founder and CEO of Loyal, a biotech startup developing drugs to extend dog lifespan. I also dabble in biotech & deep-tech investing.
Before that, I was a D.Phil. student at Oxford studying the health economics of gene therapy (St Peter’s College) & Chief of Staff to Laura Deming at Longevity Fund. I studied neuroscience and nanobiotechnology at the University of Texas at Austin and Uppsala Universitet in Sweden. I worked in the laboratories of Dr. Evan Snyder at the Sanford Consortium of Regenerative Medicine on novel enteric neuron disease therapeutics, and of Dr. Richard Morrisett and Dr. Keith Stevenson at The University of Texas at Austin on the development of a novel fluorescent silver-nanocluster-based neuronal tracers.
I am interested in biotechnology, specifically unravelling and developing therapeutics for pathological aging. I am also interested in healthcare systems, specifically the application of socialized healthcare practices to the United States and the economic incentivization of preventative and curative medicine.
I go by Celine Halioua, although in reality I actually have six names. All hyphenated.
My mom is from Rabat, Morocco, my father from Berlin, Germany, and I was born in Austin, Texas. I have studied in Texas, Sweden, Germany, and England. I am not yet sure where my home is. Until then, you can find me in various San Francisco coffee shops.
Press
Bloomberg: Silicon Valley wants dogs to live longer so humans do too
The Times: A Dog’s Life Can Be Longer, Promises Tech Startup
Out of the Crisis #12: Curative founder Fred Turner and Celine Halioua on diagnostic supply chains, scaling up testing, and partnering with government (Podcast)
Build the Future: Celine Halioua of Loyal - The Future of Aging, Longevity, and Dogs (Podcast)
Twitter: @celinehalioua